期刊文献+

寻常型银屑病患者血清白介素-21、白介素-31水平及其与病情严重程度的相关性研究 被引量:4

Relevance between levels of serum IL-21 and IL-31 and disease severity in patients with psoriasis vulgaris
下载PDF
导出
摘要 目的检测寻常型银屑病患者血清白介素-21(IL-21)、白介素-31(IL-31)水平,并探讨其与银屑病面积与严重性指数(PASI)评分之间的相关性。方法采用ELISA法检测25例寻常型银屑病患者(观察组)与25例健康人(对照组)的血清IL-21、IL-31水平,并进行比较。对寻常型银屑病患者血清IL-21及IL-31水平与其PASI评分进行相关性分析。结果观察组血清IL-21及IL-31水平均明显高于对照组(P<0.05);进展期组患者血清IL-21及IL-31水平明显高于稳定期组(P<0.05)。IL-21水平与PASI评分呈正相关(r=0.425,P=0.026);IL-31水平与PASI评分呈正相关(r=0.352,P=0.015)。结论寻常型银屑病患者血清IL-21、IL-31水平显著高于正常水平,且与疾病严重程度呈正相关,提示IL-21、IL-31可能在寻常型银屑病的发生发展中发挥重要作用。 Objective To detect the levels of serum intedeukin (IL)-21 and IL-31 in patients with psoriasis vulgaris, and to explore their relationship with psoriasis area and severity index (PASI). Methods Enzyme linked immunosorbent assay (ELISA) was applied to detect the levels of serum IL-21 and IL-31 in 25 patients with psoriasis vulgaris (observation group) and 25 healthy people (control group) , and the results were compared. And the relationships between the levels of serum IL- 21 and IL-31 and PASI score in observation group were analyzed. Results Observation group was evidently higher in the levels of serum IL-21 and IL-31 than control group (P 〈0.05 ) , and progression group significantly higher than stable group (P 〈 0.05 ). Both IL-21 and IL-31 were in positive association with PASI score (r = 0. 425, P = 0. 026 ; r = 0. 352, P = 0. 015). Conclusion Serum IL-21 and IL-31 levels are higher in patients with psoriasis vulgaris than in normal people, and are in positive association with disease severity, suggesting that IL-21 and IL-31 may play an important role in the development and progression of psoriasis vulgaris.
出处 《实用临床医药杂志》 CAS 2015年第17期71-73,共3页 Journal of Clinical Medicine in Practice
基金 中国高校医学期刊临床专项资金(11523004)
关键词 白介素-21 白介素-31 银屑病 PASI评分 interleukin-21 interleukin-31 psoriasis vulgaris psoriasis area and severity index
  • 相关文献

参考文献15

  • 1Singh S P,Zhang H H,Tsang H,et al.PLZF Regulates CCR6 and Is Critical for the Acquisition and Maintenance of the Th17 Phenotype in Human Cells[J].J Immunol,2015,194(9):4350. 被引量:1
  • 2Theodoropoulos D S,Morris M S,Morris D L.Sustained improvement of psoriatic lesions in the course of sublingual immunotherapy for airborne allergens:clinical evidence of crosstolerance[J].Eur Rev Med Pharmacol Sci,2015,19(3):392. 被引量:1
  • 3Allen M J,Fan Y Y,Monk J M,et al.n-3 PUFAs reduce Thelper 17 cell differentiation by decreasing responsiveness to interleukin-6 in isolated mouse splenic CD4+T cells[J].J Nutr,2014,144(8):1306. 被引量:1
  • 4Di Fusco D,Izzo R,Figliuzzi M M,et al.IL-21 as a therapeutic target in inflammatory disorders[J].Expert Opin Ther Targets,2014,18(11):1329. 被引量:1
  • 5Menon R,David B G.Itolizumab-a humanized anti-CD6monoclonal antibody with a better side effects profile for the treatment of psoriasis[J].Clin Cosmet Investig Dermatol,2015,7(8):215. 被引量:1
  • 6Chamoun A,Goudetsidis L,Poot F,et al.Psoriasis and depression[J].Rev Med Brux,2015,36(1):23. 被引量:1
  • 7Sarra M,Pallone F,Monteleone G.Interleukin-21 in chronic inflammatory diseases[J].Biofactors,2013,39(4):368. 被引量:1
  • 8Gedebjerg A,Johansen C,Kragballe K,et al.IL-20,IL-21and p40:potential biomarkers of treatment response for ustekinumab[J].Acta Derm Venereol,2013,93(2):150. 被引量:1
  • 9Sarra M,Caruso R,Cupi M L,et al.IL-21 promotes skin recruitment of CD4(+)cells and drives IFN-γ-dependent epidermal hyperplasia[J].J Immunol,2011,186(9):5435. 被引量:1
  • 10Costanzo A,Chimenti M S,Botti E,et al.IL-21 in the pathogenesis and treatment of skin diseases[J].J Dermatol Sci,2010,60(2):61. 被引量:1

二级参考文献36

  • 1田晗,郑捷.银屑病与免疫分子调控网络[J].国际皮肤性病学杂志,2006,32(1):26-29. 被引量:5
  • 2黄琨,刘厚君,涂亚庭.寻常型银屑病患者皮损中白介素-22和S100A7,A8,A9mRNA的表达及关系[J].中国皮肤性病学杂志,2007,21(3):138-140. 被引量:9
  • 3Tesmer LA,Lundy SK,Sarkar S,et al.Th17 cells in human disease.Immunol Rev,2008,223:87-113. 被引量:1
  • 4Mills KH.Induction,function and regulation of IL-17-producing T cells.Eur J Immunol,2008,38(10):2636-2649. 被引量:1
  • 5Romagnani S.Human Th17 cells.Arthritis Res Ther,2008,10(2):206. 被引量:1
  • 6Wolk K,Witte E,Witte K,et al.Biology of interleukin-22.Semin Immunopathol,2010,32(1):17-31. 被引量:1
  • 7Lowes MA,Kikuchi T,Fuentes-Duculan J,et al.Psoriasis vulgaris lesions contain discrete populstions of Th1 and Th17 T cells.J Invest Dermatol,2008,128(5):1207-1211. 被引量:1
  • 8Ma HL,Liang S,Li J,et al.IL-22 is required for Th17 cellmediated pathology in a mouse model of psoriasis-like skin inflammation.J Clin Invest,2008,118(2):597-607. 被引量:1
  • 9Caproni M,Antiga E,Melani L,et al.Serum levels of IL-17 and IL-22 are reduced by etanercept,but not by acitretin,in patients with psoriasis:a randomized-controlled trial.J Clin Immunol,2009,29(2):210-214. 被引量:1
  • 10Moll JM, Wrigh TV. Psoriatic arthritis. Semin [ J ]. Arthritis Rheum, 1973,3(1) :55 -78. 被引量:1

共引文献43

同被引文献31

引证文献4

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部